151 related articles for article (PubMed ID: 10995209)
1. Antiproliferative effect of a lectin- and anti-Thy-1.2 antibody-targeted HPMA copolymer-bound doxorubicin on primary and metastatic human colorectal carcinoma and on human colorectal carcinoma transfected with the mouse Thy-1.2 gene.
Ríhová B; Jelínková M; Strohalm J; St'astný M; Hovorka O; Plocová D; Kovár M; Dráberová L; Ulbrich K
Bioconjug Chem; 2000; 11(5):664-73. PubMed ID: 10995209
[TBL] [Abstract][Full Text] [Related]
2. Polymeric drugs based on conjugates of synthetic and natural macromolecules. II. Anti-cancer activity of antibody or (Fab')(2)-targeted conjugates and combined therapy with immunomodulators.
Ríhová B; Jelínková M; Strohalm J; Subr V; Plocová D; Hovorka O; Novák M; Plundrová D; Germano Y; Ulbrich K
J Control Release; 2000 Feb; 64(1-3):241-61. PubMed ID: 10640661
[TBL] [Abstract][Full Text] [Related]
3. Star structure of antibody-targeted HPMA copolymer-bound doxorubicin: a novel type of polymeric conjugate for targeted drug delivery with potent antitumor effect.
Kovár M; Strohalm J; Etrych T; Ulbrich K; Ríhová B
Bioconjug Chem; 2002; 13(2):206-15. PubMed ID: 11906257
[TBL] [Abstract][Full Text] [Related]
4. Potential of lectin-N-(2-hydroxypropyl)methacrylamide copolymer-drug conjugates for the treatment of pre-cancerous conditions.
Wróblewski S; Berenson M; Kopecková P; Kopecek J
J Control Release; 2001 Jul; 74(1-3):283-93. PubMed ID: 11489508
[TBL] [Abstract][Full Text] [Related]
5. Starlike vs. classic macromolecular prodrugs: two different antibody-targeted HPMA copolymers of doxorubicin studied in vitro and in vivo as potential anticancer drugs.
Jelínková M; Strohalm J; Etrych T; Ulbrich K; Ríhová B
Pharm Res; 2003 Oct; 20(10):1558-64. PubMed ID: 14620507
[TBL] [Abstract][Full Text] [Related]
6. Biorecognition of HPMA copolymer-lectin conjugates as an indicator of differentiation of cell-surface glycoproteins in development, maturation, and diseases of human and rodent gastrointestinal tissues.
Wróblewski S; Berenson M; Kopecková P; Kopecek J
J Biomed Mater Res; 2000 Sep; 51(3):329-42. PubMed ID: 10880074
[TBL] [Abstract][Full Text] [Related]
7. Targeting of human and mouse T-lymphocytes by monoclonal antibody-HPMA copolymer-doxorubicin conjugates directed against different T-cell surface antigens.
Jelínková M; Strohalm J; Plocová D; Subr V; St'astný M; Ulbrich K; Ríhová B
J Control Release; 1998 Mar; 52(3):253-70. PubMed ID: 9743446
[TBL] [Abstract][Full Text] [Related]
8. The influence of a colonic microbiota on HPMA copolymer lectin conjugates binding in rodent intestine.
Wróblewski S; Ríhová B; Rossmann P; Hudcovicz T; Reháková Z; Kopecková P; Kopecek J
J Drug Target; 2001 Apr; 9(2):85-94. PubMed ID: 11697110
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes.
Ríhová B; Etrych T; Pechar M; Jelínková M; Stastný M; Hovorka O; Kovár M; Ulbrich K
J Control Release; 2001 Jul; 74(1-3):225-32. PubMed ID: 11489498
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo effect of HPMA copolymer-bound doxorubicin targeted to transferrin receptor of B-cell lymphoma 38C13.
Kovár M; Strohalm J; Ulbrich K; Ríhová B
J Drug Target; 2002 Feb; 10(1):23-30. PubMed ID: 11996083
[TBL] [Abstract][Full Text] [Related]
11. HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity.
Etrych T; Strohalm J; Kovár L; Kabesová M; Ríhová B; Ulbrich K
J Control Release; 2009 Nov; 140(1):18-26. PubMed ID: 19632282
[TBL] [Abstract][Full Text] [Related]
12. Design of novel bioconjugates for targeted drug delivery.
Lu ZR; Shiah JG; Sakuma S; Kopecková P; Kopecek J
J Control Release; 2002 Jan; 78(1-3):165-73. PubMed ID: 11772458
[TBL] [Abstract][Full Text] [Related]
13. HPMA copolymer-bound doxorubicin targeted to tumor-specific antigen of BCL1 mouse B cell leukemia.
Kovár M; Mrkvan T; Strohalm J; Etrych T; Ulbrich K; Stastný M; Ríhová B
J Control Release; 2003 Oct; 92(3):315-30. PubMed ID: 14568412
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of bioadhesive lectin-HPMA copolymer-cyclosporin conjugates.
Lu ZR; Gao SQ; Kopecková P; Kopecek J
Bioconjug Chem; 2000; 11(1):3-7. PubMed ID: 10639078
[TBL] [Abstract][Full Text] [Related]
15. Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer-doxorubicin conjugates to human colon cancer cells.
David A; Kopecková P; Minko T; Rubinstein A; Kopecek J
Eur J Cancer; 2004 Jan; 40(1):148-57. PubMed ID: 14687799
[TBL] [Abstract][Full Text] [Related]
16. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. II. Processing in epithelial ovarian carcinoma cells in vitro.
Omelyanenko V; Gentry C; Kopecková P; Kopecek J
Int J Cancer; 1998 Feb; 75(4):600-8. PubMed ID: 9466663
[TBL] [Abstract][Full Text] [Related]
17. Lectin-mediated drug targeting: preparation, binding characteristics, and antiproliferative activity of wheat germ agglutinin conjugated doxorubicin on Caco-2 cells.
Wirth M; Fuchs A; Wolf M; Ertl B; Gabor F
Pharm Res; 1998 Jul; 15(7):1031-7. PubMed ID: 9688056
[TBL] [Abstract][Full Text] [Related]
18. Preparation of Fab' from murine IgG2a for thiol reactive conjugation.
Fowers KD; Callahan J; Byron P; Kopecek JI
J Drug Target; 2001; 9(4):281-94. PubMed ID: 11697031
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis of cultured rat glomerular mesangial cells induced by IgG2a monoclonal anti-Thy-1 antibodies.
Sato T; van Dixhoorn MG; Schroeijers WE; Huizinga TW; Reutelingsperger CP; van Es LA; Daha MR
Kidney Int; 1996 Feb; 49(2):403-12. PubMed ID: 8821824
[TBL] [Abstract][Full Text] [Related]
20. A possibility to overcome P-glycoprotein (PGP)-mediated multidrug resistance by antibody-targeted drugs conjugated to N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer carrier.
St'astný M; Strohalm J; Plocová D; Ulbrich K; Ríhová B
Eur J Cancer; 1999 Mar; 35(3):459-66. PubMed ID: 10448300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
